Showing results (401-410 of 824) with videos related to

Sort By:
Pageof 83
Blood|July 23, 2025
A BCMA-mRNA vaccine is a promising therapeutic for multiple myelomaDebasmita Dutta, Jiye Liu, Kenneth Wen, et al.
Leukemia|January 14, 2022
Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myelomaJohannes M Waldschmidt, Andrew J Yee, Tushara Vijaykumar, et al.
Future Oncology (London, England)|April 3, 2015
The investigational proteasome inhibitor ixazomib for the treatment of multiple myelomaPaul G Richardson, Philippe Moreau, Jacob P Laubach, et al.
Experimental Hematology|March 8, 2002
Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: functional implicationsYu-Tzu Tai, Klaus Podar, Stine-Kathrein Kraeft, et al.
Cancer Research|April 17, 2002
S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in miceSuzanne Lentzsch, Michael S Rogers, Richard LeBlanc, et al.
British Journal of Haematology|July 13, 2010
Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myelomaPaul G Richardson, Ashraf Z Badros, Sundar Jagannath, et al.
The Journal of Pharmacy and Pharmacology|August 21, 2010
JS-K has potent anti-angiogenic activity in vitro and inhibits tumour angiogenesis in a multiple myeloma model in vivoTanyel Kiziltepe, Kenneth C Anderson, Jeffery L Kutok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2017
Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple MyelomaMorihiko Sagawa, Hiroto Ohguchi, Takeshi Harada, et al.
Oncoimmunology|August 18, 2025
CyTOF profiling of bone marrow immune dynamics across myeloma stagesDana Cholujova, Gabor Beke, Lubos Klucar, et al.
Pageof 83